company

ULTRALYDKLINIKKEN AS

3044 DRAMMEN

Return on Equity
209,84 %
Current Ratio
0,45
Debt-to-Equity Ratio
−0,8
Key figures (NOK)2022
Revenue2 832 000
Net Income−128 000
Total Assets278 000
Total Equity−61 000
Income (NOK)2022
Revenue2 832 000
Expenditure2 960 000
Operating Profit−128 000
Financial Income2 000
Financial Costs2 000
Financial Balance0
Earnings Before Tax−128 000
Tax0
Net Income−128 000
Balance (NOK)2022
Total Fixed Assets148 000
Total Current Assets131 000
Total Assets278 000
Total Retained Equity−161 000
Total Equity−61 000
Total Long-Term Debt49 000
Total Current Debt290 000
Total Equity and Debt278 000
Cash flow (NOK)2022
Sales Income2 829 000
Other Income3 000
Revenue2 832 000
Cost of Goods Sold2 000
Salary Costs1 586 000
Depreciation0
Impairment0
Expenditure2 960 000
Operating Profit−128 000
Financial Income2 000
Financial Costs2 000
Financial Balance0
Dividends0
Net Income−128 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets97 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets51 000
Total Fixed Assets148 000
Stock0
Total Investments0
Cash, Bank125 000
Total Current Assets131 000
Total Assets278 000
Total Equity−61 000
Short-Term Group Debt0
Total Long-Term Debt49 000
Creditors104 000
Unpaid Taxes60 000
Dividends0
Other Current Debt127 000
Total Current Debt290 000
Total Equity and Debt278 000
Financial indicators2022
Return on Equity209,84 %
Debt-to-Equity Ratio−0,8
Operating Profit Margin−4,52 %
Current Ratio0,45
Quick Ratio0,45
Equity Ratio−0,22
Gross Profit Margin99,93 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English